Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association
Recommendations
As issued by the authors
Strategic investments in biobanking and genomic research across all populations to enhance variant interpretation and improve risk prediction models
A multidisciplinary approach bridging scientific innovation, clinical application and policy development to optimize the benefits of genetic and genomic testing while mitigating disparities and ethical challenges
Original publication
Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association. Circulation. Published 13 November 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →